Tuesday, June 30, 2015 9:51:03 PM
Whilst we have raised the previosly estimated $2 million required to obtain US Food and Drug Administration approval
of the patented process for humans and to make the product available to our targeted markets our due diligence has
been successfully completed and contracts now signed subject only to the remittance and clearance of funds.The
new loan investment in the Company will allow trials to recommence. The delay in receiving the new funding, due to
circumstances beyond our control or influence, has prevented us from pursuing the FDA approval, appointing our
preferred investor relations and public relations consultants and commissioning the new website.
http://www.otcmarkets.com/financialReportViewer?symbol=TCEL&id=138904
You should not make any trades or decisions based upon anything said or written by posts on this board with regard to investments without consulting a professional financial planner/adviser..
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM